000906898 001__ 906898
000906898 005__ 20240625095116.0
000906898 0247_ $$2doi$$a10.3389/fphar.2022.837088
000906898 0247_ $$2Handle$$a2128/34404
000906898 0247_ $$2pmid$$a35418860
000906898 0247_ $$2WOS$$aWOS:000783551000001
000906898 037__ $$aFZJ-2022-01753
000906898 082__ $$a610
000906898 1001_ $$0P:(DE-HGF)0$$aKörner, Jannis$$b0
000906898 245__ $$aSodium channels and local anesthetics – old friends with new perspectives
000906898 260__ $$aLausanne$$bFrontiers Media$$c2022
000906898 3367_ $$2DRIVER$$aarticle
000906898 3367_ $$2DataCite$$aOutput Types/Journal article
000906898 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1684131583_11960
000906898 3367_ $$2BibTeX$$aARTICLE
000906898 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000906898 3367_ $$00$$2EndNote$$aJournal Article
000906898 520__ $$aThe long history of local anesthetics (LAs) starts out in the late 19th century when the content of coca plant leaves was discovered to alleviate pain. Soon after, cocaine was established and headed off to an infamous career as a substance causing addiction. Today, LAs and related substances—in modified form—are indispensable in our clinical everyday life for pain relief during and after minor and major surgery, and dental practices. In this review, we elucidate on the interaction of modern LAs with their main target, the voltage-gated sodium channel (Navs), in the light of the recently published channel structures. Knowledge of the 3D interaction sites of the drug with the protein will allow to mechanistically substantiate the comprehensive data available on LA gating modification. In the 1970s it was suggested that LAs can enter the channel pore from the lipid phase, which was quite prospective at that time. Today we know from cryo-electron microscopy structures and mutagenesis experiments, that indeed Navs have side fenestrations facing the membrane, which are likely the entrance for LAs to induce tonic block. In this review, we will focus on the effects of LA binding on fast inactivation and use-dependent inhibition in the light of the proposed new allosteric mechanism of fast inactivation. We will elaborate on subtype and species specificity and provide insights into modelling approaches that will help identify the exact molecular binding orientation, access pathways and pharmacokinetics. With this comprehensive overview, we will provide new perspectives in the use of the drug, both clinically and as a tool for basic ion channel research.
000906898 536__ $$0G:(DE-HGF)POF4-5252$$a5252 - Brain Dysfunction and Plasticity (POF4-525)$$cPOF4-525$$fPOF IV$$x0
000906898 536__ $$0G:(GEPRIS)291198853$$aDFG project 291198853 - FOR 2518: Funktionale Dynamik von Ionenkanälen und Transportern - DynIon - $$c291198853$$x1
000906898 7001_ $$0P:(DE-Juel1)181061$$aAlbani, Simone$$b1
000906898 7001_ $$0P:(DE-HGF)0$$aVishal Sudha Bhagavath Eswaran$$b2
000906898 7001_ $$0P:(DE-HGF)0$$aRöhl, Anna B$$b3
000906898 7001_ $$0P:(DE-Juel1)145921$$aRossetti, Giulia$$b4$$eCorresponding author
000906898 7001_ $$0P:(DE-HGF)0$$aLampert, Angelika$$b5$$eCorresponding author
000906898 773__ $$0PERI:(DE-600)2587355-6$$a10.3389/fphar.2022.837088$$p837088$$tFrontiers in pharmacology$$v13$$x1663-9812$$y2022
000906898 8564_ $$uhttps://juser.fz-juelich.de/record/906898/files/Invoice_2022-0592646-0.pdf
000906898 8564_ $$uhttps://juser.fz-juelich.de/record/906898/files/fphar-13-837088.pdf$$yOpenAccess
000906898 8767_ $$82022-0592646-0$$92022-02-16$$aBelegnr. 1200178605$$d2022-03-28$$eAPC$$jZahlung erfolgt$$zUSD 737,50
000906898 909CO $$ooai:juser.fz-juelich.de:906898$$pdnbdelivery$$popenCost$$pVDB$$pdriver$$pOpenAPC$$popen_access$$popenaire
000906898 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)181061$$aForschungszentrum Jülich$$b1$$kFZJ
000906898 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)145921$$aForschungszentrum Jülich$$b4$$kFZJ
000906898 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5252$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
000906898 9141_ $$y2023
000906898 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2021-02-04
000906898 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-02-04
000906898 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2021-02-04
000906898 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-02-04
000906898 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000906898 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000906898 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bFRONT PHARMACOL : 2019$$d2021-02-04
000906898 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2021-02-04
000906898 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2021-02-04
000906898 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2021-02-04
000906898 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2021-02-04
000906898 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2021-02-04
000906898 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2021-02-04
000906898 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-02-04
000906898 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Blind peer review$$d2021-02-04
000906898 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2021-02-04
000906898 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2021-02-04
000906898 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2021-02-04
000906898 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2021-02-04
000906898 920__ $$lyes
000906898 9201_ $$0I:(DE-Juel1)IAS-5-20120330$$kIAS-5$$lComputational Biomedicine$$x0
000906898 9201_ $$0I:(DE-Juel1)INM-9-20140121$$kINM-9$$lComputational Biomedicine$$x1
000906898 980__ $$ajournal
000906898 980__ $$aVDB
000906898 980__ $$aUNRESTRICTED
000906898 980__ $$aI:(DE-Juel1)IAS-5-20120330
000906898 980__ $$aI:(DE-Juel1)INM-9-20140121
000906898 980__ $$aAPC
000906898 9801_ $$aAPC
000906898 9801_ $$aFullTexts